Followers | 7 |
Posts | 1577 |
Boards Moderated | 0 |
Alias Born | 02/27/2014 |
Saturday, February 21, 2015 11:47:52 AM
1) Q4 disappointing in terms of revenue and earnings
2) Q1 not going to be too great, but somewhat better than Q4.
3) minimal dilution expectation going forward
4) Tiger Woods a transaction that will never make money for MSLP
So, in order for the price to go up short term, any of these assumptions need to change for the better. Any further dilution will kill the stock for good and make it a no go stock for institutional investors.
I believe we need to wait for guidance for Q2 for any real upside though as Musclepharm is adjusting to the Walmart and Sam's Club deal. Yearly guidance numbers are not trusted as he will miss Q4.
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM